Placental growth factor testing for suspected pre-eclampsia
Authors:
Open Access
- 1 May 2019
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 393 (10183) , 1775-1776
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trialThe Lancet, 2019
- Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort studyThe Lancet Child & Adolescent Health, 2018
- Phenotypes of Pregnant Women Who Subsequently Develop Hypertension in PregnancyJournal of the American Heart Association, 2018
- Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study2018
- Maternal Vascular Malperfusion and Adverse Perinatal Outcomes in Low-Risk Nulliparous WomenObstetrics & Gynecology, 2017
- Endothelial Dysfunction in Severe Preeclampsia is Mediated by Soluble Factors, Rather than Extracellular VesiclesScientific Reports, 2017
- Is Canada Ready to Adopt Maternal Placental Growth Factor Testing to Improve Clinical Outcomes for Women with Suspected Preeclampsia?Journal of Obstetrics and Gynaecology Canada, 2017
- Pre-eclampsiaThe Lancet, 2016
- Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected PreeclampsiaCirculation, 2012
- Pre-eclampsiaThe Lancet, 2010